Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/28133
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hodges R.J. | en |
dc.contributor.author | Wallace E.M. | en |
dc.date.accessioned | 2021-05-14T09:28:27Z | en |
dc.date.available | 2021-05-14T09:28:27Z | en |
dc.date.copyright | 2012 | en |
dc.date.created | 20121107 | en |
dc.date.issued | 2012-11-07 | en |
dc.identifier.citation | Journal of Maternal-Fetal and Neonatal Medicine. 25 (11) (pp 2149-2153), 2012. Date of Publication: November 2012. | en |
dc.identifier.issn | 1476-7058 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/28133 | en |
dc.description.abstract | Clinical and experimental studies suggest that the growth-restricted fetus at increased risk of impaired cardiovascular function that likely contributes to both increased mortality rate and in survivors, to cardiovascular dysfunction apparent in childhood and later life. Fetal growth restriction is also associated with a high risk of preterm birth. Accordingly, the growth-restricted fetus is more likely than average to receive antenatal glucocorticoids to accelerate lung maturation in preparation for birth. However, glucocorticoids are powerful regulators of vascular tone and antenatal glucocorticoid administration to the intrauterine growth restriction (IUGR) fetus results in systemic cardiovascular changes that are not observed in the healthy normal grown fetus. These responses to glucocorticoids may disturb the IUGR fetus' ability to appropriately compensate to placental insufficiency. Indeed is it possible that in the setting of severe IUGR exogenous glucocorticoids are detrimental rather than beneficial to the fetus © 2012 Informa UK, Ltd. | en |
dc.language | en | en |
dc.language | English | en |
dc.publisher | Informa Healthcare (69-77 Paul Street, London EC2A 4LQ, United Kingdom) | en |
dc.title | Mending a growth-restricted fetal heart: Should we use glucocorticoids. | en |
dc.type | Review | en |
dc.identifier.affiliation | Obstetrics and Gynaecology (Monash Women's) | - |
dc.type.studyortrial | Review article (e.g. literature review, narrative review) | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.3109/14767058.2012.697940 | en |
dc.publisher.place | United Kingdom | en |
dc.identifier.pubmedid | 22764774 [http://www.ncbi.nlm.nih.gov/pubmed/?term=22764774] | en |
dc.identifier.source | 365856331 | en |
dc.identifier.institution | (Hodges, Wallace) Maternal Fetal Medicine, Monash Medical Centre, Southern Health, VIC, Australia (Hodges, Wallace) Department of Obstetrics and Gynaecology, Southern Clinical School, Monash University, 246 Clayton Road, VIC, 3168, Australia | en |
dc.description.address | E.M. Wallace, Department of Obstetrics and Gynaecology, Southern Clinical School, Monash University, 246 Clayton Road, VIC, 3168, Australia. E-mail: euan.wallace@monash.edu | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2013 Elsevier B.V., All rights reserved. | en |
dc.subect.keywords | Betamethasone Fetal growth restriction Glucocorticoids IUGR Placental insufficiency | en |
dc.identifier.authoremail | Wallace E.M.; euan.wallace@monash.edu | en |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | Review | - |
crisitem.author.dept | Obstetrics and Gynaecology (Monash Women's) | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.